SCHEMBL4149778

SCHEMBL4149778

Brc1csc(-c2ccsc2-c2ccsc2-c2cccs2)c1Br

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.33
KDM4E B2RXH2 4/20 0.33
HPGD P15428 3/20 0.33
HSD17B10 Q99714 2/20 0.33
ALDH1A1 P00352 2/20 0.33
GAA P10253 2/20 0.33
TSHR P16473 1/20 0.33
PTPRC P08575 1/20 0.33
MEN1 O00255 3/20 0.33
KMT2A Q03164 3/20 0.33
TDP1 Q9NUW8 4/20 0.32
RAB9A P51151 2/20 0.32
PPARG P37231 1/20 0.32
NCOA2 Q15596 1/20 0.32
NCOA1 Q15788 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
RXFP1 Q9HBX9 1/20 0.32
NCOA3 Q9Y6Q9 1/20 0.32
L3MBTL1 Q9Y468 2/20 0.32
NPC1 O15118 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4613684 0.98 MAPT (0.34) MAPTKDM4EHPGDHSD17B10ALDH1A1
SCHEMBL4585410 0.84 PTPRC (0.36) MAPTKDM4EHPGDHSD17B10ALDH1A1
SCHEMBL4585893 0.84 PTPRC (0.36) MAPTKDM4EHPGDHSD17B10ALDH1A1
SCHEMBL4614749 0.84 MEN1 (0.39) MAPTKDM4EHPGDHSD17B10ALDH1A1
SCHEMBL22734786 0.80 PTPRC (0.41) MAPTKDM4EHPGDHSD17B10ALDH1A1
SCHEMBL22763791 0.80 PTPRC (0.41) MAPTKDM4EHPGDHSD17B10ALDH1A1
SCHEMBL22734807 0.80 PTPRC (0.41) MAPTKDM4EHPGDHSD17B10ALDH1A1
SCHEMBL22734772 0.80 PTPRC (0.41) MAPTKDM4EHPGDHSD17B10ALDH1A1
SCHEMBL22763310 0.80 PTPRC (0.41) MAPTKDM4EHPGDHSD17B10ALDH1A1
SCHEMBL992407 0.77 ALDH1A1 (0.36) MAPTKDM4EHPGDHSD17B10ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090005557-A1 Electron-Conjugated Organic Silane Compound and Production Method Thereof SHARP KABUSHIKI KAISHA (JP) 2009-01-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090005557-A1 Electron-Conjugated Organic Silane Compound and Production Method Thereof MLX, RNF31, RPS4X MAPT 4190/4885KDM4E 230/4885HPGD 4354/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.